BeOne Medicines (ONC) executive compensation, 2026 proxy

John V. Oyler, Co-Founder, Chairman and Chief Executive Officer, was paid $17.9M in 2025, down 14% from $20.8M the year before. The CEO-to-median-employee pay ratio was 218:1, on median employee pay of $82,226.

Filed
April 28, 2026
Pay year
2025
Named executives
5
CEO total pay
$17.9M-14% vs prior year
CEO to median employee
218:1median $82,226
CEO pay in equity
84%$15M in awards
Prior say-on-pay support
88%of votes cast
2025 Revenue
$5.3B40% year-over-year growth
Company Bonus Performance
148%Exceeding objectives
Five-Year TSR
17.6%28th percentile of peer group
Total Shareholder Return Since IPO
864%98th percentile of peer group

How Oyler was paid

$17.9M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary6%Stock awards63%Option awards21%Non-equity incentive9%All other compensation1%

Named executive officers

ExecutiveTotal
John V. OylerCo-Founder, Chairman and Chief Executive Officer$17,943,521
Aaron RosenbergChief Financial Officer$6,428,374
Dr. Xiaobin WuPresident and Chief Operating Officer$12,029,451
Dr. Lai WangPresident, Global Head of Research and Development$18,319,310
Chan LeeSenior Vice President, General Counsel and Corporate Secretary$5,055,306

What changed and why

  • $17.9MCEO total compensation decreased to $17,943,521 in 2025 from $20,836,439 in 2024.
  • $5.3BRevenues reached $5.3 billion, representing year-over-year growth of 40%.
  • 148%The annual bonus program resulted in Company performance of 148% of target.
  • $10.0MPresident of R&D received a one-time promotional equity award of $10.0 million.
  • 864%Total Shareholder Return reached 864% since IPO, placing the company at the 98th percentile of peers.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.